April 15 (Reuters) - Amylin Pharmaceuticals Inc:
* Issues media statement pertaining to Carl Icahn's Letter to chairman - filing
* Says welcomes opportunity to meet Icahn and Eastbourne Capital management
again
* Says remains open to constructive discussions without preconditions
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Issues media statement pertaining to Carl Icahn's Letter to chairman - filing
* Says welcomes opportunity to meet Icahn and Eastbourne Capital management
again
* Says remains open to constructive discussions without preconditions
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.